Biocon starts biotech classes in India; AMEC to buy Foster Wheeler; FDA wants a robot;

> The FDA got a hearty slap on the back from Sen. Tom Harkin (D-IA), congratulating it on getting started with its voluntary program for oversight of drug compounders. Release

> The FDA is taking enforcement action against companies selling what it considers to be unapproved OTC drugs containing codeine. Blog post

> AMEC intends to buy U.S.-based Foster Wheeler ($FWLT) for $3.2 billion, getting its pharmaceutical plant design services in the process. Release

> Denmark's Novo Nordisk has been sued by a group of healthcare purchasing companies in the U.S. alleging it has blocked generic copies of its Prandin diabetes drug from the market. Story

> Biocon is working with California-based Keck Graduate Institute to establish a biotech training institute in Bangalore offering a 16-week program. Report

And Finally... The FDA is taking bids for a robot that could be used to process the large number of samples contained in some pharmacokinetic and bioavailability/bioequivalence studies. Solicitation

 

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.